Synovics Pharmaceuticals - Withdrawal of Registration Statement (RW)
September 09 2008 - 10:45AM
Edgar (US Regulatory)
Synovics Pharmaceuticals, Inc.
5360 Northwest 35
th
Avenue
Ft. Lauderdale, FL 33309
954-486-4590
September 9, 2008
VIA EDGAR TRANSMISSION
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
|
|
|
|
Re:
|
Synovics Pharmaceuticals, Inc. (the
Company
)
|
|
|
Registration Statement on Form S-3
|
|
|
File No. 333-135981
|
|
|
Filed July 24, 2006
|
Ladies and Gentlemen:
The Company hereby respectfully requests, pursuant to Rule 477 under the Securities Act of 1933, as amended, that the Securities and Exchange Commission (the
Commission
) consent to the withdrawal by the Company of its Registration Statement on Form S-3 filed with the Commission on July 24, 2006 (File No. 333-135981) (the
Registration Statement
).
The Company requests this withdrawal because it has determined not to pursue the registration of the securities included in the Registration Statement at this time. No securities were offered or sold
pursuant to the Registration Statement. Please apply the Companys filing fee to its account with the Commission.
Thank you for your assistance in this matter.
|
|
|
|
|
|
|
Synovics Pharmaceuticals, Inc.
|
|
|
|
By:
|
/s/ Steve Getraer
|
|
|
|
Name:
|
|
Steve Getraer
|
|
|
|
Title:
|
|
Chief Financial Officer
|
|
Synovics Pharmaceuticals (CE) (USOTC:SYVC)
Historical Stock Chart
From May 2024 to Jun 2024
Synovics Pharmaceuticals (CE) (USOTC:SYVC)
Historical Stock Chart
From Jun 2023 to Jun 2024